CN102256959B - 用于治疗的噻吩化合物 - Google Patents

用于治疗的噻吩化合物 Download PDF

Info

Publication number
CN102256959B
CN102256959B CN200980151290.7A CN200980151290A CN102256959B CN 102256959 B CN102256959 B CN 102256959B CN 200980151290 A CN200980151290 A CN 200980151290A CN 102256959 B CN102256959 B CN 102256959B
Authority
CN
China
Prior art keywords
carboxy
alkyl
amino
disease
alkoxycarbonyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN200980151290.7A
Other languages
English (en)
Chinese (zh)
Other versions
CN102256959A (zh
Inventor
P·奥斯伯格
L·乔纳森
A·荷兰德
A·艾斯兰德
P·康拉德森
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Beal Clou New Cool Co ltd
Cpl Bcx Pharmaceutical Co ltd
If New Sail LLC
Pick J F Watt Chaanning Ltd
Original Assignee
BIO CLAU MIX PHARMACEUTICAL Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BIO CLAU MIX PHARMACEUTICAL Ltd filed Critical BIO CLAU MIX PHARMACEUTICAL Ltd
Publication of CN102256959A publication Critical patent/CN102256959A/zh
Application granted granted Critical
Publication of CN102256959B publication Critical patent/CN102256959B/zh
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/24—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/28—Halogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/38—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D333/40—Thiophene-2-carboxylic acid

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Psychology (AREA)
  • Endocrinology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Obesity (AREA)
  • Cardiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
CN200980151290.7A 2008-10-17 2009-10-19 用于治疗的噻吩化合物 Expired - Fee Related CN102256959B (zh)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
SE0850043 2008-10-17
SE0850043-1 2008-10-17
SE0850050-6 2008-10-23
SE0850050 2008-10-23
PCT/SE2009/051187 WO2010044743A1 (en) 2008-10-17 2009-10-19 Novel thiophene compounds for use in theraphy

Publications (2)

Publication Number Publication Date
CN102256959A CN102256959A (zh) 2011-11-23
CN102256959B true CN102256959B (zh) 2014-01-08

Family

ID=42106726

Family Applications (1)

Application Number Title Priority Date Filing Date
CN200980151290.7A Expired - Fee Related CN102256959B (zh) 2008-10-17 2009-10-19 用于治疗的噻吩化合物

Country Status (9)

Country Link
US (1) US8710246B2 (enExample)
EP (1) EP2350042B1 (enExample)
JP (1) JP5646495B2 (enExample)
KR (1) KR101743049B1 (enExample)
CN (1) CN102256959B (enExample)
BR (1) BRPI0920850A2 (enExample)
CA (1) CA2740969C (enExample)
ES (1) ES2551744T3 (enExample)
WO (2) WO2010044743A1 (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10092000B2 (en) 2010-07-13 2018-10-09 Stc.Unm Structure, synthesis, and applications for oligo phenylene ethynylenes (OPEs)
WO2013055417A2 (en) * 2011-07-08 2013-04-18 Stc.Unm Thiophene based oligomers as light activated biocides
EP2817304A4 (en) 2011-07-14 2015-01-21 Biochromix Newco Ab Novel compounds and their use in therapy
WO2013020096A2 (en) 2011-08-03 2013-02-07 Stc.Unm Antimicrobial materials and methods
WO2013036196A1 (en) * 2011-09-07 2013-03-14 Biochromix Ab Novel thiophene compounds and method for in vivo imaging
SE536793C2 (sv) 2012-07-02 2014-08-19 Richter Life Science Dev Ab Detektion av kolhydrater
US9968698B2 (en) 2013-11-08 2018-05-15 Stc. Unm Charged singlet-oxygen sensitizers and oppositely-charged surfactants
US10533991B2 (en) 2014-03-14 2020-01-14 Stc.Unm P-phenylene ethynylene compounds as bioactive and detection agents
CA2973982C (en) 2015-01-14 2018-04-03 David G. Whitten Conjugated polyelectrolytes and methods of using the same
CA3000625C (en) 2015-10-01 2024-02-13 Richter Life Science Development Ab Detection of microbial peptides
US10772851B2 (en) 2017-02-03 2020-09-15 Aaron Kurt Neumann Treatment and prevention of fungal infections
US20200261605A1 (en) * 2019-01-24 2020-08-20 Alzeca Biosciences, LLC Functionalized liposomes for imaging misfolded proteins
CN119264384A (zh) * 2023-07-04 2025-01-07 宁德时代未来能源(上海)研究院有限公司 化合物、钙钛矿太阳能电池和用电装置
CN118724890A (zh) * 2024-06-05 2024-10-01 佛山大学 一种抗细菌生物膜剂的荧光示踪成像探针分子及其制备方法和应用

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4861692A (en) * 1986-12-22 1989-08-29 Fuji Electric Company, Ltd. Electrophotographic photosensitive material containing thiophene compound
US5747525A (en) * 1992-02-19 1998-05-05 Industrial Technology Research Institute Medicinal thiophene compounds
WO1998023269A1 (en) * 1996-11-26 1998-06-04 Purdue Research Foundation Polythiophene anti-tumor agents
EP1111695A2 (en) * 1999-12-24 2001-06-27 Matsushita Electric Industrial Co., Ltd. Organic electroluminescent device
WO2005109005A1 (en) * 2004-05-10 2005-11-17 Biochromix Ab Methods for determining conformational changes and self-assembly of proteins
WO2007091973A1 (en) * 2006-02-09 2007-08-16 Biochromix Ab Methods for detection of pathogenic prion proteins associated with prion diseases, using conjugated polyelectrolytes

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS63158557A (ja) * 1986-12-23 1988-07-01 Fuji Electric Co Ltd 電子写真用感光体
JP3885244B2 (ja) * 1994-12-05 2007-02-21 松下電器産業株式会社 オリゴチオフェン重合体、及びオリゴチオフェン化合物の製造方法
TW200413009A (en) * 2002-10-04 2004-08-01 Univ Pennsylvania Biphenyls and fluorenes as imaging agents in alzheimer's disease
WO2005002288A1 (ja) * 2003-03-14 2005-01-06 Semiconductor Energy Laboratory Co., Ltd. 共役分子及びそれを用いた電界発光素子、並びに電界発光素子を用いた電子機器
JP4392499B2 (ja) * 2004-12-07 2010-01-06 国立大学法人 筑波大学 キラルポリマーの製造方法及びキラルポリマー並びにキラルポリマーの動的な電気化学的方法による光学活性制御
JPWO2007063950A1 (ja) * 2005-12-01 2009-05-07 国立大学法人東北大学 コンフォーメーション病診断および治療用の長波長蛍光物質およびその使用
WO2007109545A2 (en) * 2006-03-16 2007-09-27 The Regents Of The University Of California Copolymers of alkoxythiophene
EP2125800A1 (en) * 2007-01-22 2009-12-02 AstraZeneca AB Novel heteroaryl substituted imidazo ý1,2 -a¨pyridine derivatives
CA2721770A1 (en) * 2007-04-18 2008-10-30 Biochromix Ab Medical use of conjugated polyelectrolytes

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4861692A (en) * 1986-12-22 1989-08-29 Fuji Electric Company, Ltd. Electrophotographic photosensitive material containing thiophene compound
US5747525A (en) * 1992-02-19 1998-05-05 Industrial Technology Research Institute Medicinal thiophene compounds
WO1998023269A1 (en) * 1996-11-26 1998-06-04 Purdue Research Foundation Polythiophene anti-tumor agents
EP1111695A2 (en) * 1999-12-24 2001-06-27 Matsushita Electric Industrial Co., Ltd. Organic electroluminescent device
WO2005109005A1 (en) * 2004-05-10 2005-11-17 Biochromix Ab Methods for determining conformational changes and self-assembly of proteins
WO2007091973A1 (en) * 2006-02-09 2007-08-16 Biochromix Ab Methods for detection of pathogenic prion proteins associated with prion diseases, using conjugated polyelectrolytes

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
Electronic Structure of Push-Pull Molecules Based on Thiophene Oligomers;L. E. Bolivar-Marinez, et al.,;《J. Phys. Chem.》;19961231;第100卷(第26期);第11029-11032页 *
Energy Gaps of α, α’-Substituted Oligothiophenes from Semiempirical, Ab Initio, and Density Functional Methods;Marcos A. De Oliveira, et al.,;《J. Phys. Chem. A》;20000812;第104卷(第35期);第8256-8262页 *
Functionalized Oligothiophenes for Optoelectronic Applications: 3’,4’,3’’’,4’’’-Tetra [(methoxycarbonyl)methyl]-2,2’:5’,2’’:5’’,2’’’:5’’’,2’’’’-quinquithiophene and Related Polymers;W. Porzio, et al.,;《Chem. Mater.》;20041222;第17卷(第2期);第242-249页 *
Photophysical Studies of α,ω-Dicyano-oligothiophenes NC(C4H2S)nCN (n=1-6);J. Pina, et al.,;《J. Phys. Chem. B》;20060311;第110卷(第13期);第6499-6505页 *
Radical Ions of α,α’-Bis(diphenylamino)-capped Oligothiophenes: A Combined Spectroelectrochemical and Theoretical Study;Dirk Rohde, et al.,;《J. Phys. Chem. B》;20060404;第110卷(第16期);第8223-8231页 *
Structural and electronic effects induced by carboxylic acid substitution in isomeric 2,2’-bithiophenes and oligothiophenes: A computational study;Jordi Casanovas;《Polymer》;20050809;第46卷(第22期);第9452-9560页 *

Also Published As

Publication number Publication date
EP2350042A4 (en) 2013-07-31
WO2010044744A1 (en) 2010-04-22
CA2740969A1 (en) 2010-04-22
KR101743049B1 (ko) 2017-06-02
US8710246B2 (en) 2014-04-29
BRPI0920850A2 (pt) 2016-09-13
WO2010044743A1 (en) 2010-04-22
JP5646495B2 (ja) 2014-12-24
EP2350042A1 (en) 2011-08-03
US20120157516A1 (en) 2012-06-21
CN102256959A (zh) 2011-11-23
JP2012505879A (ja) 2012-03-08
ES2551744T3 (es) 2015-11-23
CA2740969C (en) 2017-01-17
KR20110099089A (ko) 2011-09-06
EP2350042B1 (en) 2015-07-29

Similar Documents

Publication Publication Date Title
CN102256959B (zh) 用于治疗的噻吩化合物
KR20150090269A (ko) 다환형 화합물 및 이의 사용 방법
JP5815552B2 (ja) 眼疾患を治療する化合物および方法
CN103467417B (zh) 牛蒡子苷元碳酰胺衍生物及其制备方法、包含该衍生物的组合物、及其用途
US9359311B2 (en) Substituted aromatic oligomers
PT2328417E (pt) Compostos, composições e métodos para o tratamento de doenças causadas por -amiloide e sinucleinopatias
US20180002298A1 (en) Compounds for the treatment of neurodegenerative diseases
AU2006210778B2 (en) Tumor necrosis factor inhibitors
CN102807557B (zh) 3h-1,2-二硫环戊烯-3-硫酮类化合物及其应用
KR20180089511A (ko) 3,5-디페닐-디아졸 화합물의 수용성 유도체
WO2013134371A1 (en) Methods and compounds to be used in the treatment of neurodegenerative diseases
CN107304172A (zh) 八氢蒽类化合物及其制备方法和用途
CN100588655C (zh) 酰肼类化合物及其在用于治疗心血管疾病的药物组合物中的应用
KR20150002713A (ko) 단백질 응집 저해제로서의 페닐-우레아 및 페닐-카바메이트 유도체
CN107629022A (zh) 一种抗菌增效剂及其制法和用途
WO2005085189A2 (en) Analogues of congo red and evaluation of their anti-prion activity
JP2021523934A (ja) ミトコンドリア脱共役剤として有用なアミノピラジンおよび関連化合物
CN110551156B (zh) 特定基团修饰的n1,n3取代4,5-二芳基咪唑环卡宾铑配合物及其制备方法和应用
CN110117302B (zh) 神经退行性疾病的治疗药物及其应用
CN110612305B (zh) 硫酸乙酰肝素糖模拟化合物及其医药与化妆品用途
WO2016000599A1 (zh) C-苯并五元杂芳环类芳基葡萄糖苷衍生物及其制备方法与用途
CN106866555A (zh) 1‑二苯甲基‑4‑甲基哌嗪类化合物其制备方法和应用
CN103724271B (zh) 取代咪唑-1-乙烯类化合物及其用途
WO2013036196A1 (en) Novel thiophene compounds and method for in vivo imaging
AU2012200538A1 (en) Tumor necrosis factor inhibitors

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C53 Correction of patent of invention or patent application
CB03 Change of inventor or designer information

Inventor after: P.Oseberg

Inventor after: L. Jonathan

Inventor after: Herland Anna

Inventor after: A Ai Silande

Inventor after: Konradsson Per

Inventor before: P.Oseberg

Inventor before: L. Jonathan

Inventor before: Herland Anna

COR Change of bibliographic data

Free format text: CORRECT: INVENTOR; FROM: ASBERG PETER JOHANSSON LEIF HERLAND ANNA TO: ASBERG PETER JOHANSSON LEIF HERLAND ANNA ASLUND ANDREAS KONRADSSON PETER

C14 Grant of patent or utility model
GR01 Patent grant
CP01 Change in the name or title of a patent holder

Address after: Stockholm

Patentee after: CPL BCX Pharmaceutical Co.,Ltd.

Address before: Stockholm

Patentee before: Beal Clou new cool Co.,Ltd.

Address after: Solna, Sweden

Patentee after: Pick J F Watt Chaanning Ltd.

Address before: Solna, Sweden

Patentee before: Biochromix Newco AB

CP01 Change in the name or title of a patent holder
TR01 Transfer of patent right

Effective date of registration: 20170908

Address after: Stockholm

Patentee after: Beal Clou new cool Co.,Ltd.

Address before: Solna, Sweden

Patentee before: Pick J F Watt Chaanning Ltd.

Effective date of registration: 20170908

Address after: Graz, Austria

Patentee after: If the new sail, LLC

Address before: Stockholm

Patentee before: CPL BCX Pharmaceutical Co.,Ltd.

TR01 Transfer of patent right
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20140108

Termination date: 20181019

CF01 Termination of patent right due to non-payment of annual fee